会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Perfusion culture method and perfusion culture device for organ or tissue
    • 灌注培养法和器官或组织灌注培养装置
    • US08771931B2
    • 2014-07-08
    • US13574855
    • 2011-01-25
    • Takashi TsujiKazuhisa Nakao
    • Takashi TsujiKazuhisa Nakao
    • A01N1/00
    • A01N1/0247C12M21/08C12M29/10
    • Disclosed are a perfusion culture method and a perfusion culture device whereby a perfusate can be delivered to all parts of an organ or tissue so that the organ or tissue can be preserved while sufficiently maintaining the function thereof. Specifically disclosed is a method for perfusion culture of an organ or tissue removed from a mammal, said organ or tissue having been removed together with a second organ or tissue connected to the aforesaid organ or tissue in vivo, which comprises a step for fixing said second organ or tissue so as to hang the aforesaid organ or tissue and a step for perfusing blood vessels in the aforesaid organ or tissue with a perfusate.
    • 公开了一种灌注培养方法和灌注培养装置,其中灌注液可以递送到器官或组织的所有部分,使得可以在充分保持其功能的同时保存器官或组织。 具体公开了一种用于从哺乳动物,所述器官或组织移除的器官或组织的灌注培养的方法,所述器官或组织与连接到所述前述器官或组织的体内的第二器官或组织一起被去除,其包括用于固定所述第二 器官或组织,以悬挂上述器官或组织,以及用灌注液灌注前述器官或组织中的血管的步骤。
    • 33. 发明授权
    • Apparatus and method for perfusion and determining the viability of an organ
    • 用于灌注和确定器官活力的装置和方法
    • US08741555B2
    • 2014-06-03
    • US10845154
    • 2004-05-14
    • John BrassilSimona Baicu
    • John BrassilSimona Baicu
    • A01N1/00A01N1/02
    • A61B5/14525A01N1/02A01N1/0247A61B5/413
    • An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. During the period in which the organ is preserved and/or maintained, the organ may be additionally be perfused to obtain data regarding the fluid and/or organ. The data may then be used to ultimately provide information regarding the perfusion efficacy and allow for altering of the perfusion parameters.
    • 器官灌注装置和方法监测,维持和/或恢复器官的活力并保存器官用于储存和/或运输。 其他装置包括器官输送器,器官盒和器官诊断装置。 该方法包括在低温和/或正常体温温度下灌注器官,优选在用于器官运输和/或储存的低温器官冲洗之后。 该方法可以在先前或随后的器官的静态或灌注低温暴露下进行。 在保存和/或保持器官的期间,可以另外灌注器官以获得关于流体和/或器官的数据。 然后可以使用数据来最终提供关于灌注功效的信息并允许改变灌注参数。
    • 34. 发明授权
    • Specimen preservation chamber and method
    • 样品保存室和方法
    • US08722403B2
    • 2014-05-13
    • US13353914
    • 2012-01-19
    • Sanjay S. Kumar
    • Sanjay S. Kumar
    • A01N1/00
    • A01N1/0252A01N1/0263A61B10/0096
    • The present invention comprises a specimen preserver. A bubble reservoir is used to hold a preserving liquid such as artificial cerebrospinal liquid (aCSF). Oxygen is introduced into the aCSF by a gas diffuser which is attached to the bubble reservoir. The tissue samples are contained in one or more chambers in a holding platform. The platform is suspended well above the bottom of the bubble reservoir. The lower portion of each of the chambers is open toward the bottom of the bubble reservoir, but is covered by a fine mesh. The gas introduced into the aCSF circulates within the bubble reservoir. However, the tissue samples are not directly exposed to the gas bubbles because the fine mesh excludes the bubbles from the chambers in which the tissue samples are housed.
    • 本发明包括样品保存器。 使用气泡储存器容纳诸如人造脑脊液(aCSF)的保存液体。 氧气通过连接到气泡储存器的气体扩散器引入到aCSF中。 组织样品包含在保持平台中的一个或多个室中。 平台悬浮在气泡储存器底部的上方。 每个室的下部朝向气泡储存器的底部开口,但被细网覆盖。 引入aCSF的气体在气泡储存器内循环。 然而,组织样品不直接暴露于气泡,因为细网不排除来自容纳组织样本的腔室中的气泡。
    • 35. 发明授权
    • Fluidics based pulsatile perfusion preservation device and method
    • 基于流体的脉动灌注保存装置及方法
    • US08685709B2
    • 2014-04-01
    • US12890348
    • 2010-09-24
    • Leonid BuneginEdward F. Gelineau
    • Leonid BuneginEdward F. Gelineau
    • A01N1/00A01N1/02
    • A01N1/0247
    • In one embodiment, a preservation apparatus is described that includes a storage compartment. The storage compartment is configured to hold an organ or tissue and a preservation fluid. A cover assembly is configured to engage the storage compartment. The cover assembly includes a support element, wherein the support element together with the storage compartment define a storage chamber. The cover assembly also includes a lid and a gas permeable membrane disposed between the lid and the support element. The gas permeable membrane and the support element together define a perfusion chamber configured to hold preservation fluid and an organ or tissue during use.
    • 在一个实施例中,描述了包括存储隔间的保存装置。 储存室构造成保持器官或组织和保存液体。 盖组件构造成接合储藏室。 所述盖组件包括支撑元件,其中所述支撑元件与所述储存室一起限定存储室。 盖组件还包括盖和设置在盖和支撑元件之间的透气膜。 气体可渗透膜和支撑元件一起限定了在使用期间构造成保持保存流体和器官或组织的灌注室。
    • 40. 发明授权
    • Tissue preservation and fixation method
    • 组织保存和固定方法
    • US08460859B2
    • 2013-06-11
    • US12447773
    • 2007-10-26
    • Virginia A. EspinaLance A. LiottaDavid Geho
    • Virginia A. EspinaLance A. LiottaDavid Geho
    • A01N1/00
    • G01N1/30A01N1/00
    • This invention relates, e.g., to a composition that, at room temperature, when contacted with a sample comprising phosphoproteins, can fix and stabilize cellular phosphoproteins, preserve cellular morphology, and allow the sample to be frozen to generate a cryostat frozen section suitable for molecular analysis. The composition comprises (1) a fixative that is effective to fix the phosphoproteins, and that has a sufficient water content to be soluble for a stabilizer and/or a permeability enhancing agent); (2) a stabilizer, comprising (a) a kinase inhibitor and (b) a phosphatase inhibitor and, optionally, (c) a protease (e.g., proteinase) inhibitor; and (3) a permeability enhancing agent (e.g. PEG). Methods are described for preserving phosphoproteins, using such a composition. Also described are endogenous surrogate markers for monitoring protein degradation, including the loss of posttranslational modifications (such as phosphorylation), e.g. the following removal of a cell or tissue from a subject; and exogenous molecular sentinels (e.g. phosphoproteins attached to magnetic nanoparticles) that allow one to evaluate the processing history of a cellular or tissue population sample.
    • 本发明涉及例如在室温下与包含磷蛋白的样品接触时可以固定和稳定细胞磷酸蛋白的组合物,保留细胞形态,并允许样品冷冻以产生适于分子的低温恒温器冷冻切片 分析。 组合物包含(1)固定磷酸蛋白有效的固定剂,并且其具有足够的水含量可溶于稳定剂和/或渗透性增强剂); (2)稳定剂,其包含(a)激酶抑制剂和(b)磷酸酶抑制剂和任选的(c)蛋白酶(例如蛋白酶)抑制剂; 和(3)渗透性增强剂(例如PEG)。 描述了使用这种组合物来保存磷蛋白的方法。 还描述了用于监测蛋白质降解的内源替代标记,包括翻译后修饰(例如磷酸化)的丧失,例如, 以下从受试者中除去细胞或组织; 和外源性分子前哨蛋白(例如连接到磁性纳米颗粒的磷酸蛋白),其允许评价细胞或组织群体样品的加工历史。